56 related articles for article (PubMed ID: 35247953)
21. Multiple relapses of Plasmodium vivax malaria acquired from West Africa and association with poor metabolizer CYP2D6 variant: a case report.
He X; Pan M; Zeng W; Zou C; Pi L; Qin Y; Zhao L; Qin P; Lu Y; Baird JK; Huang Y; Cui L; Yang Z
BMC Infect Dis; 2019 Aug; 19(1):704. PubMed ID: 31399061
[TBL] [Abstract][Full Text] [Related]
22. Novel Insights into Plasmodium vivax Therapeutic Failure: CYP2D6 Activity and Time of Exposure to Malaria Modulate the Risk of Recurrence.
Silvino ACR; Kano FS; Costa MA; Fontes CJF; Soares IS; de Brito CFA; Carvalho LH; Sousa TN
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32122891
[No Abstract] [Full Text] [Related]
23. History and Current Status of Malaria in Korea.
Chai JY
Infect Chemother; 2020 Sep; 52(3):441-452. PubMed ID: 32869559
[TBL] [Abstract][Full Text] [Related]
24. Several Plasmodium vivax relapses after correct primaquine treatment in a patient with impaired cytochrome P450 2D6 function.
Martin Ramírez A; Lombardia González C; Soler Maniega T; Gutierrez Liarte Á; Domingo García D; Lanza Suárez M; Bernal Fernández MJ; Rubio JM
Malar J; 2020 Jul; 19(1):259. PubMed ID: 32680522
[TBL] [Abstract][Full Text] [Related]
25. Case report: recurrence of Plasmodium vivax malaria due to defective cytochrome P450 2D6 function in Pos Lenjang, Pahang, Malaysia.
Mat Salleh NH; Rahman MFA; Samsusah S; De Silva JR; Ng DC; Ghozali AH; Tan JH; Lai MY; Amir A; Liew JWK; Lau YL
Trans R Soc Trop Med Hyg; 2020 Sep; 114(9):700-703. PubMed ID: 32511702
[TBL] [Abstract][Full Text] [Related]
26. Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group.
Caudle KE; Sangkuhl K; Whirl-Carrillo M; Swen JJ; Haidar CE; Klein TE; Gammal RS; Relling MV; Scott SA; Hertz DL; Guchelaar HJ; Gaedigk A
Clin Transl Sci; 2020 Jan; 13(1):116-124. PubMed ID: 31647186
[TBL] [Abstract][Full Text] [Related]
27. Association of Impaired Cytochrome P450 2D6 Activity Genotype and Phenotype With Therapeutic Efficacy of Primaquine Treatment for Latent Plasmodium vivax Malaria.
Baird JK; Louisa M; Noviyanti R; Ekawati L; Elyazar I; Subekti D; Chand K; Gayatri A; Instiaty ; Soebianto S; Crenna-Darusallam C; Djoko D; Hasto BD; Meriyenes D; Wesche D; Nelwan EJ; Sutanto I; Sudoyo H; Setiabudy R
JAMA Netw Open; 2018 Aug; 1(4):e181449. PubMed ID: 30646129
[TBL] [Abstract][Full Text] [Related]
28. Malaria control and chemoprophylaxis policy in the Republic of Korea Armed Forces for the previous 20 years (1997-2016).
Im JH; Huh K; Yoon CG; Woo H; Lee JS; Chung MH; Klein TA; Jung J
Malar J; 2018 Aug; 17(1):295. PubMed ID: 30111314
[TBL] [Abstract][Full Text] [Related]
29. High Risk of Plasmodium vivax Malaria Following Splenectomy in Papua, Indonesia.
Kho S; Andries B; Poespoprodjo JR; Commons RJ; Shanti PAI; Kenangalem E; Douglas NM; Simpson JA; Sugiarto P; Anstey NM; Price RN
Clin Infect Dis; 2019 Jan; 68(1):51-60. PubMed ID: 29771281
[TBL] [Abstract][Full Text] [Related]
30. Primaquine pharmacology in the context of CYP 2D6 pharmacogenomics: Current state of the art.
Marcsisin SR; Reichard G; Pybus BS
Pharmacol Ther; 2016 May; 161():1-10. PubMed ID: 27016470
[TBL] [Abstract][Full Text] [Related]
31. Differential CYP 2D6 metabolism alters primaquine pharmacokinetics.
Potter BM; Xie LH; Vuong C; Zhang J; Zhang P; Duan D; Luong TL; Bandara Herath HM; Dhammika Nanayakkara NP; Tekwani BL; Walker LA; Nolan CK; Sciotti RJ; Zottig VE; Smith PL; Paris RM; Read LT; Li Q; Pybus BS; Sousa JC; Reichard GA; Marcsisin SR
Antimicrob Agents Chemother; 2015 Apr; 59(4):2380-7. PubMed ID: 25645856
[TBL] [Abstract][Full Text] [Related]
32. Dramatic post-splenectomy onset of malaria caused by latent Plasmodium vivax in a female immigrant with severe immunological anaemia.
Tagariello G; Sartori R; Inojosa WO; Candiotto L; Radossi P; Scarpa E; Tassinari C
Blood Transfus; 2014 Jul; 12(3):428-30. PubMed ID: 24887227
[No Abstract] [Full Text] [Related]
33. First evaluation of glucose-6-phosphate dehydrogenase (G6PD) deficiency in vivax malaria endemic regions in the Republic of Korea.
Goo YK; Ji SY; Shin HI; Moon JH; Cho SH; Lee WJ; Kim JY
PLoS One; 2014; 9(5):e97390. PubMed ID: 24853873
[TBL] [Abstract][Full Text] [Related]
34. Primaquine failure and cytochrome P-450 2D6 in Plasmodium vivax malaria.
Bennett JW; Pybus BS; Yadava A; Tosh D; Sousa JC; McCarthy WF; Deye G; Melendez V; Ockenhouse CF
N Engl J Med; 2013 Oct; 369(14):1381-2. PubMed ID: 24088113
[No Abstract] [Full Text] [Related]
35. Multiple-clone activation of hypnozoites is the leading cause of relapse in Plasmodium vivax infection.
de Araujo FC; de Rezende AM; Fontes CJ; Carvalho LH; Alves de Brito CF
PLoS One; 2012; 7(11):e49871. PubMed ID: 23185469
[TBL] [Abstract][Full Text] [Related]
36. Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites.
Imwong M; Snounou G; Pukrittayakamee S; Tanomsing N; Kim JR; Nandy A; Guthmann JP; Nosten F; Carlton J; Looareesuwan S; Nair S; Sudimack D; Day NP; Anderson TJ; White NJ
J Infect Dis; 2007 Apr; 195(7):927-33. PubMed ID: 17330781
[TBL] [Abstract][Full Text] [Related]
37. Practical PCR genotyping protocols for Plasmodium vivax using Pvcs and Pvmsp1.
Imwong M; Pukrittayakamee S; Grüner AC; Rénia L; Letourneur F; Looareesuwan S; White NJ; Snounou G
Malar J; 2005 Apr; 4():20. PubMed ID: 15854233
[TBL] [Abstract][Full Text] [Related]
38. Radical cure of infections with Plasmodium cynomolgi: a function of total 8-aminoquinoline dose.
Schmidt LH; Fradkin R; Vaughan D; Rasco J
Am J Trop Med Hyg; 1977 Nov; 26(6 Pt 1):1116-28. PubMed ID: 413444
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
